Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Puhr

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Endocrine-Related Cancer|January 18, 2020
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancerMartina Gruber, Lavinia Ferrone, Martin Puhr, et al.
The American Journal of Pathology|October 9, 2012
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205Martin Puhr, Julia Hoefer, Georg Schäfer, et al.
European Journal of Immunology|November 17, 2017
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cellsBeatrix Loeschenberger, Lea Niess, Reinhard Würzner, et al.
Clinical Genitourinary Cancer|May 9, 2025
The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes-A Retrospective Cohort TrialNastasiia Artamonova, Leon Galleé, Hannes Neuwirt, et al.
The American Journal of Pathology|April 4, 2009
Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinasesHannes Neuwirt, Martin Puhr, Frédéric R Santer, et al.
Biology Direct|November 12, 2024
The impact of androgen-induced translation in modulating androgen receptor activityJustus S Israel, Laura-Maria Marcelin, Sherif Mehralivand, et al.
Frontiers in Molecular Biosciences|April 16, 2026
Pitfalls of onco-metabolomics: impact of sample integrity on metabolomic investigations in more than 4500 human serum samples from ten different cohortsMichael Ladurner, Selina Strathmeyer, Tobias Ameismeier, et al.
Oncotarget|August 20, 2016
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cellsLuigi Ippolito, Alberto Marini, Lorenzo Cavallini, et al.
Plos One|February 14, 2015
Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivoHannes Neuwirt, Elisabeth Wabnig, Clemens Feistritzer, et al.
Oncogene|April 2, 2021
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancerMartin Puhr, Andrea Eigentler, Florian Handle, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Endocrine-Related Cancer|January 18, 2020
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancerMartina Gruber, Lavinia Ferrone, Martin Puhr, et al.
The American Journal of Pathology|October 9, 2012
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205Martin Puhr, Julia Hoefer, Georg Schäfer, et al.
European Journal of Immunology|November 17, 2017
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cellsBeatrix Loeschenberger, Lea Niess, Reinhard Würzner, et al.
Clinical Genitourinary Cancer|May 9, 2025
The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes-A Retrospective Cohort TrialNastasiia Artamonova, Leon Galleé, Hannes Neuwirt, et al.
The American Journal of Pathology|April 4, 2009
Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinasesHannes Neuwirt, Martin Puhr, Frédéric R Santer, et al.
Biology Direct|November 12, 2024
The impact of androgen-induced translation in modulating androgen receptor activityJustus S Israel, Laura-Maria Marcelin, Sherif Mehralivand, et al.
Frontiers in Molecular Biosciences|April 16, 2026
Pitfalls of onco-metabolomics: impact of sample integrity on metabolomic investigations in more than 4500 human serum samples from ten different cohortsMichael Ladurner, Selina Strathmeyer, Tobias Ameismeier, et al.
Oncotarget|August 20, 2016
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cellsLuigi Ippolito, Alberto Marini, Lorenzo Cavallini, et al.
Plos One|February 14, 2015
Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivoHannes Neuwirt, Elisabeth Wabnig, Clemens Feistritzer, et al.
Oncogene|April 2, 2021
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancerMartin Puhr, Andrea Eigentler, Florian Handle, et al.
Pageof 7